Literature DB >> 26450367

The Effect of Fetal Bovine Serum (FBS) on Efficacy of Cellular Reprogramming for Induced Pluripotent Stem Cell (iPSC) Generation.

Daekee Kwon1, Jin-Su Kim, Byung-Hyun Cha, Kwang-Sook Park, Inbo Han, Kyung-Soon Park, Hojae Bae, Myung-Kwan Han, Kwang-Soo Kim, Soo-Hong Lee.   

Abstract

Induced pluripotent stem cells (iPSCs) are pivotal to the advancement of regenerative medicine. However, the low efficacy of iPSC generation and insufficient knowledge about the reprogramming mechanisms involved in somatic cell/adult stem cell reversion to a pluripotent phenotype remain critical hurdles to the therapeutic application of iPSCs. The present study investigated whether the concentration of fetal bovine serum (FBS), a widely employed cell culture additive, can influence the cellular reprogramming efficacy (RE) of human adipose-derived stem cells (hADSCs) to generate iPSCs. Compared with the typically employed concentration of FBS (10%), high concentrations (20% and 30%) increased the RE of hADSCs by approximately twofold, whereas a low concentration (5%) decreased the RE by the same extent. Furthermore, cell counting kit-8 (CCK-8), bromodeoxyuridine (BrdU) incorporation, and fluorescence-activated cell sorting (FACS) assays showed that hADSC proliferation during reprogramming was significantly enhanced by FBS at 20% and 30%, whereas quantitative polymerase chain reaction (qPCR) and Western blotting assays revealed a concomitant decrease in p53, p51, and p21 expression. In addition, the efficacy of retrovirus-mediated transduction into hADSCs was increased by approximately 10% at high concentrations of FBS. It was confirmed that platelet-derived growth factor in the FBS enhanced proliferation and reprogramming efficacy. Finally, the generated iPSCs showed a normal karyotype, the same fingerprinting pattern as parental hADSCs, a genome-wide transcriptome pattern similar to that of human embryonic stem cells (hESCs), and in vivo pluripotency. In conclusion, the current investigation demonstrated that high concentrations of FBS can modulate molecular and cellular mechanisms underlying the reprogramming process in hADSCs, thereby augmenting the cellular RE for iPSC generation.

Entities:  

Mesh:

Year:  2015        PMID: 26450367     DOI: 10.3727/096368915X689703

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  6 in total

Review 1.  Reprogramming Enhancers in Somatic Cell Nuclear Transfer, iPSC Technology, and Direct Conversion.

Authors:  Daekee Kwon; Minjun Ji; Seunghee Lee; Kwang Won Seo; Kyung-Sun Kang
Journal:  Stem Cell Rev Rep       Date:  2017-02       Impact factor: 5.739

2.  Comparative analysis of the survival and regeneration potential of juvenile and matured earthworm, Eudrilus eugeniae, upon in vivo and in vitro maintenance.

Authors:  Kamarajan Rajagopalan; Jackson Durairaj Selvan Christyraj; Karthikeyan Subbiahanadar Chelladurai; Jemima Kamalapriya John Samuel Gnanaraja; Johnson Retnaraj Samuel Selvan Christyraj
Journal:  In Vitro Cell Dev Biol Anim       Date:  2022-08-03       Impact factor: 2.723

3.  Allogeneic Serum and Macromolecular Crowding Maintain Native Equine Tenocyte Function in Culture.

Authors:  Andrea Rampin; Ioannis Skoufos; Michael Raghunath; Athina Tzora; Nikolaos Diakakis; Nikitas Prassinos; Dimitrios I Zeugolis
Journal:  Cells       Date:  2022-05-05       Impact factor: 7.666

4.  Generation of Genetically Stable Human Direct-Conversion-Derived Neural Stem Cells Using Quantity Control of Proto-oncogene Expression.

Authors:  Kwon Daekee; Han Mi-Jung; Ji Minjun; Ahn Hee-Jin; Seo Kwang-Won; Kang Kyung-Sun
Journal:  Mol Ther Nucleic Acids       Date:  2018-12-20       Impact factor: 8.886

5.  Differential gene expression by lithium chloride induction of adipose-derived stem cells into neural phenotype cells.

Authors:  Samaneh Farrokhfar; Taki Tiraihi; Mansoureh Movahedin; Hossein Azizi
Journal:  Iran J Basic Med Sci       Date:  2020-04       Impact factor: 2.699

Review 6.  Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis.

Authors:  Jui-Hao Lee; Jen-Wei Liu; Shinn-Zong Lin; Horng-Jyh Harn; Tzyy-Wen Chiou
Journal:  Cell Transplant       Date:  2018-07-23       Impact factor: 4.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.